A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
NeoTX Therapeutics Ltd.
Actym Therapeutics, Inc.
Ascentage Pharma Group Inc.
Symphogen A/S
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Centre Hospitalier Universitaire Vaudois
Quadriga Biosciences, Inc.
Shionogi Inc.
Incyte Corporation
Incyte Corporation
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)